Raphamin for acute sinus infection in adults
Treatments studied
Part of Ear, nose & throat, Infections, Lungs & breathing clinical trials.
This trial tests a new medicine called Raphamin for treating sudden sinus infection (acute rhinosinusitis) in adults. It compares the medicine to a placebo to see if it can reduce symptoms like facial pain and pressure when started within the first 2 days of illness.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old
- You have sinus symptoms like facial pain or pressure that started within the last 2 days
- You have not used steroid nasal sprays or antibiotics in the past 30 days
- You do not have certain other medical conditions (like chronic sinusitis, nasal polyps, or severe heart/liver/kidney disease)
- You are not pregnant, breastfeeding, or planning to become pregnant during the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests treatments for the common cold, sinus pain, or sore throat caused by a virus. It compares different options to see which works best for reducing symptoms like runny nose, congestion, and cough.
This study tests whether a medicine called Raphamin can safely and effectively treat acute bronchitis (a chest infection with cough) in adults. Raphamin may help reduce cough and breathing problems in the early stages of this condition.
This trial tests if Raphamin can safely treat common cold symptoms in children. It is for kids who have had cold symptoms for less than 24 hours and have a fever of at least 100°F with other symptoms like stuffy nose or sore throat.
This trial tests whether nasal steroids, nasal irrigation, or oral antibiotics work best for acute sinusitis. It may help if you have ongoing sinus symptoms or a 'double-sickening' pattern after a cold.
This trial tests a new antibody medicine (CM326) for people with chronic sinusitis and nasal polyps whose symptoms persist despite standard treatments like nasal sprays. It aims to see if the drug can reduce inflammation and improve symptoms.
This study tests a new sinus stent that slowly releases medicine to treat chronic sinusitis in both nostrils. The goal is to see if it helps reduce symptoms and inflammation better than usual care.
Hear when a new Rhinosinusitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.